BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 4, 2014
View Archived Issues
Bristol-Myers Squibb designs novel NS5B inhibitors
Read More
Palatin and Gedeon Richter sign collaboration and license agreement for bremelanotide in Europe
Read More
First results of the X-VERT trial of rivaroxaban in nonvalvular AF presented
Read More
Novel anti-NRG-1 MAbs disclosed by MBL
Read More
Chinese group divulges novel ALK inhibitors
Read More
Enzyme replacement therapy tested in a murine model of human neurofibromatosis type 1
Read More
Synergistic activity of neem, karanja and aloe vera in patients with skin injuries
Read More
Lilly patents new EP4 receptor antagonists
Read More
Novartis designs new IP receptor agonists
Read More
Aurigene reports new BTK inhibitors
Read More
Phase I study of novel antifungal agent F-901318 begins
Read More
Antisense Therapeutics reports efficacy results from phase II acromegaly study of ATL-1103
Read More
FDA grants orphan drug status to Genz-682452 for Fabry's disease
Read More
Halozyme Therapeutics' PEGPH-20 program receives fast track designation
Read More
Iluvien receives marketing authorization in Sweden for chronic diabetic macular edema
Read More
Lorus Therapeutics changes name
Read More
Sanofi Pasteur reports data from final phase III efficacy study of dengue vaccine candidate
Read More
Infinity and AbbVie to develop and commercialize duvelisib in oncology
Read More
Tetraphase Pharmaceuticals reports data from phase III trial of eravacycline
Read More
XBiotech reports phase III data for Xilonix in colorectal cancer
Read More
BMS returns clazakizumab rights to Alder BioPharmaceuticals
Read More
ViiV Healthcare receives E.U. marketing authorization for Triumeq
Read More
Ryzodeg launched in first country
Read More
Cleveland BioLabs clear to submit pre-EUA for entolimod
Read More
GeNeuro reports 1-year extension study findings on GNbAC-1 for MS
Read More
First volunteers vaccinated in NIAID study of Ebola vaccine
Read More